Title: CLASSIFICATION%20OF%20ANTIPSYCHOTIC%20DRUGS
1- CLASSIFICATION OF ANTIPSYCHOTIC DRUGS
- More than 20 different antipsychotic drugs are
available for clinical use, but with certain
exceptions the differences between them are
minor. - An important distinction is drawn between the
main group, often referred to as classical or
typical antipsychotic drugs atypical
antipsychotic drugs - Atypical commonly refers to the diminished
tendency of some newer compounds to cause
unwanted motor side-effects. Their
pharmacological profile somewhat different from
that of classical pre-1980 drugs
(phenothiazines, thioxanthines and
butyrophenones).
2Click for larger picture
3 MECHANISM OF ACTION There are many type of
DA-receptors (see upper). The antipsychotic drugs
probably owe their therapeutic effects mainly to
blockade of D2 receptors. The main groups,
phenothiazines, thioxanthines and butyrophenones,
show preference for D2 over D1 receptors some
newer agents (e.g. remoxipride) are highly
selective for D2 receptors, whereas clozapine is
relatively non-selective between D1 and D2, but
has high affinity for D4. DA, the naturally
occurring agonist, interacts with D1 and D2
receptors, and both receptors are found in high
density in the corpus striatum and nucleus
accumbens. Most striatal neurons have D1
responses and most accumbens neurons have D2
responses.
4Fig.8
Click for larger picture
5Click for larger picture
6Click for larger picture
7Although D-receptor blockade occurs rapidly after
initial antipsychotic drug treatment, a
therapeutic response is not usually observed for
several weeks. The time it takes for the clinical
response to be manifested is thought to correlate
with the delayed induction of depolarization
blockade of mesolimbic DA neurons. Induction of
depolarization blockade also correlates with a
reversal of initial increase in the concentration
of DA metabolites in cerebrospinal fluid.
8Click for larger picture
9Click for larger picture
10- EFFECTS OF ANTIPSYCHOPTIC DRUGS
- 1.Central Nervous System
- Effects of antipsychotic drugs differ in normal
and psychotic individuals. - In normal individuals they produce indifference
to surrounding, paucity of thought, psychomotor
slowing, emotional quiet, reduction in initiative
and tendency to go off to sleep. Spontaneous
movements are minimized, but slurring of speech,
ataxia or motor uncoordination does not occur.
This has been referred to as the neuroleptic
syndrome and is quite different from the
sedative action of barbiturates and other
similar drugs. The effects are appreciated as
neutral and unpleasant by most normal
individuals.
11- Catalepsy arises primarily from acute blockade of
postsynaptic D2 receptors in basal ganglia. - Chlorpromazine lowers seizure threshold and can
precipitate fits in untreated epileptics. The
piperazine side chain compounds have a lower
property for this action. The temperature control
is knocked off at relatively higher doses
rendering the individual poikilothermic body
temperature falls if surrounding are cold. The
medullary respiratory and other vital centers are
not affected, except at high doses. It is very
difficult to produce coma with these drugs.
Neuroleptics, except thioridazine, have potent
antiemetic action exerted through the central
trigger zone. However, they are ineffective in
motion sickness.
12- 3.Local anaesthetic
- Chlorpromazine is as potent a local anaesthetic
as procaine. However, it is not used for this
purpose because of its irritant action. Others
have weaker membrane stabilizing action.
13- 5.Skeletal muscle
- Neuroleptics have no effects on muscle fibers or
neuromuscular transmission. They reduce certain
types of spasticity the site of action being in
the basal ganglia or medulla oblongata. Spinal
reflexes are not affected.
14- PHARMACOKINETICS
- Most neuroleptic drugs are highly lipophilic,
bind avidly to proteins, and tend to accumulate
in highly perfused tissues. Oral absorption is
often incomplete and erratic, whereas IM
injection is more reliable. With repeated
administration, variable accumulation occurs in
body fat and possibly in brain myelin. Half-lives
are generally long, and so a single daily dose is
effective. An esterified derivate of fluphenazine
requires dosing only once every few weeks. After
long-term treatment and drug administration is
stopped, therapeutic effects may outlast
significant blood concentrations by days or
weeks. This may result from tight binding of
parent drug of active metabolites in the brain.
15- ANWANTED EFFECTS
- Neuroleptic drugs are replete with side effects.
Many side effects occur early during treatment
and result from neuroleptic blockade of receptors
in the central and peripheral nervous systems
others appear later in the course of treatment
(fig.12). - 1.Extrapyramidal reactions include
- Parkinsonism, which can mimic idiopathic
Parkinsons disease but is usually of mild
degree. It responds to anticholinergic drugs or
amantadine - Akatisia is a subjective sense of restlessness
usually accompanied by wild to moderate motor
hyperactivity. It is among the most common of
side effects and usually responds to a-adrener
gic receptor antagonists, anticholinergics,
antihistamines or amantadine. Akathisia is
sometimes misinterpreted as increased agitation,
leading to increased neuroleptic dosing,
resulting in greater akathisia.
16- 2.Endocrine effects
- DA, released in the median eminence by
neurons of the tuberohypophyseal pathway acts
physiologically via D2 receptors as an inhibitor
of prolactin secretion. The result of blocking D2
receptors by antipsychotic drugs is therefore to
increase the plasma prolactin concentration,
resulting breast swelling, pain and lactation,
which can occur in men as well as women. Other
less pronounced endocrine changes including a
decrease of growth hormone secretion, but these,
unlike the prolactin response, are unimportant
clinically.
17- 4. Sedation, which tends to decrease with
continued use, occurs with many antypsychotic
drugs. Antihistamine (H1) activity is a property
of phenothiazines and contributes to their
sedative and antiemetic properties, but not to
their antipsychotic action.
18- 6.Various idiosyncratic and hypersensitivity
reaction can occur, the most important being. - Jaundice, which occurs with older phenothizines,
such as chlorpromazine. The jaundice is usually
mild, and of obstructive origin it disappears
quickly when the drug is stopped of substituded
by an antipsychotic of different class.
19Click for larger picture
20- CLINICAL USE AND EFFICACY
- Although the underlying cause of psychosis is
unknown, treatment with neuroleptic drugs usually
results in a specific improvement in psychotic
sings and symptoms and does not simply cause
sedation or reduce agitation. Modern
antipsychotic drugs allow many schizophrenics to
lead productive lives outside hospitals or less
restrictive lives within hospitals.
Unfortunately, for about half of patients with
schizophrenia, classical neuroleptics are not
completely effective in controlling positive
symptoms. The progression of negative symptoms
can lead to progressive deterioration. In
schizophrenia, negative signs and symptoms are
generally more resistant to antipsychotic drug
therapy and are commonly the cause of chronic
disability. It is likely that negative sings and
symptoms have a pathophysiological description
different from that of positive sings and
symptoms and are associated more with decreased
frontal lobe metabolic rate. In some patients,
negative sings and symptoms way worsen with
neutoleptoic treatment. The increased efficacy of
clozapine compared to traditional neuroleptics
derives primary from its greater efficacy in
improving negative sings and symptoms. -
21- The major use of antipsychotic drugs is in the
treatment of schizophrenia and other psychotic
disorders . The neuroleptics are the only
efficacious treatment for schizophrenia. Not all
patients respond, and complete normalisation of
behavior is seldom achieved. The traditional
neuroleptics are most effective in treating
positive symptoms of schizophrenia (delusions,
hallucination and thought disorders). The newer
agents with 5-HT blocking activity (e.g.sulpirid
) are effective in many patients resistant to the
traditional agent, especially in treating
negative symptoms of schizophrenia and
depression.
22- REFERENCES
- Pharmacology, Fourth Edition, H.P.Rang, M.M.Dale,
J.M.Ritter, CHURCHILL LIVINGSTONE, 2001. - Human Pharmacology, Molecular to Clinical, Third
Edition, T.Brody, J.Larner, K.Minneman, Mosby,
1998 by Mosby-Year Book,Inc. - Basic Clinical Pharmacology. A LANGE medical
book. 8 EDITION, B.G.Katzung, 2001, McGraw-Hill
Comp. - Lippincotts Illustrated Reviews Pharmacology,
2nd Edition, M.J.Mycek, R.A.Harvey P.C.Champe,
LIPPINCOTT WILLIAMS WILKINS, 2000.